Search results for: 'signaling pathways cardiovascular {{media url='
-
BA6139 Q134RSummary: Q134R, a neuroprotective hydroxyquinoline derivative, inhibits nuclear factors that activate T cell signaling. - BA1375 IlimaquinoneSummary: Ilimaquinone is a marine sponge-like metabolite that exerts antitumor activity through a GADD153-mediated signaling pathway.
- BA8535 LY900009Summary: LY900009 is a potent, orally active, signaling inhibitor that acts by selectively inhibiting gamma-secretase proteins.
- BA9119 TDI-011536Summary: TDI-011536 is a potent kinase inhibitor that interrupts signaling and may initiate proliferation of damaged cardiomyocytes.
- BA9088 IsoviolanthinSummary: Isoviolanthin is a flavonoid glycoside that, in HCC cells, inhibits epithelial mesenchymal transition (EMT) through regulation and pathways that significantly inhibit mediated migration and invasion.
-
P1124 Recombinant Human IL-9Summary: Interleukin 9, also known as IL-9, is a cytokine (cell signaling molecule) belonging to the group of interleukins. - BA6084 TJ-M2010-5Summary: TJ-M2010-5 is an inhibitor that binds to the TIR structural domain to interfere with its homodimerization and the TLR/MyD88 signaling pathway.
- BA9093 CWP232228Summary: CWP232228 is a potent and selective signaling pathway inhibitor in the nucleus that antagonizes binding to T cell factor (TCF).
- BA8616 RA839Summary: RA839 is a non-covalent small-molecule binding agent for Keap1, approximately 6 μM, and is a selective activator of Nrf2 signaling.
- BA3070 Pentagamavunon-1Summary: Pentagamavunon-1 (PGV-1), an analog of Curcumin, is orally active and induces apoptotic signaling through several mechanisms, such as inhibition and.